Companies Dominating the Typhoid Antibody Testing Market
- IDL Biotech AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- LINEAR CHEMICALS, S.L.U
- Medical Innovation Ventures Sdn Bhd
- Thermo Fisher Scientific
- Nectar Lifesciences Ltd.
- DIALAB GmbH.
- BIOSYSTEMS S.A.
- Siemens Healthcare GmbH
- NanoEnTek
- CerTest Biotec S.L.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of typhoid antibody testing is assessed at USD 1.31 billion.
The typhoid antibody testing market size was over USD 1.16 billion in 2024 and is projected to reach USD 3.01 billion by 2037, witnessing around 7.6% CAGR during the forecast period i.e., between 2025-2037. Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases will fuel the market growth.
Asia Pacific industry is predicted to account for largest revenue share of 41% by 2037, driven by increase in typhoid cases in the region.
The major players in the market are IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.